BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 27, 1998
View Archived Issues
Company Profile: Vectagen
Read More
Lamivudine consistently effective as a treatment for hepatitis B
Read More
Montelukast shows promise in the treatment of pediatric asthma patients
Read More
Company Profile: SignalSite
Read More
SciClone reacquires rights to Zadaxin in Italy
Read More
Generic controlled-release carbamazepine approved in U.K.
Read More
Ofloxacin-impregnated beads demonstrate efficacy in the prevention of osteomyelitis
Read More
LY-303366: antifungal activity in a murine model of invasive aspergillosis
Read More
Nitroquinoxalinediones for inhibiting neuronal cell death
Read More
Bronchodilating and antiinflammatory agents claimed by Nikken
Read More
Genometrix and GeneMedicine embark on high-throughput screening effort
Read More
Elan signs definitive agreement to acquire Carnrick
Read More
Pacific will begin safety trial of BOPP photodynamic therapy
Read More
ImmuLogic: Q1 1998 highlights
Read More
Sparta licenses drug delivery technology for temozolomide to Schering-Plough
Read More
Novo Nordisk sells Seroxat marketing rights to SKB
Read More
Oxandrin approved in South Korea and the Azerbaijan Republic
Read More
Cubist, Neurogen collaborate on antiinfective drug discovery
Read More
Crystaal in-licenses Neurex's Corlopam
Read More
Amgen: Q1 1998 highlights
Read More
New hirudin option now available in U.K.
Read More
Baccatin derivatives with antitumor activity developed at Tanabe Seiyaku
Read More
Cathepsin inhibitors under study at Nippon Chemiphar
Read More
Toyama focuses on cephalosporins, particularly anti-MRSA compounds
Read More
Oral levosimendan effectively substitutes for i.v. inotropic therapy
Read More
Roberts acquires Pentasa marketing rights from HMR
Read More
Dofetilide exerts atrial positive inotropic effect in AF patients following cardioversion
Read More
Glaxo Wellcome terminates clinical trial for septic shock agent
Read More
New NK1 receptor antagonist ineffective against postherpetic neuralgia
Read More
FDA advisory committee will meet to discuss Thyrogen NDA
Read More